A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...
Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...
Australian researchers warn GLP-1 weight-loss drugs may cause scurvy, the historic "pirate disease," due to poor nutrition and vitamin C deficiency risks.
Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.
Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these ...
The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...
But a new Oxford University study published in The BMJ suggests the benefits may be short-lived. Researchers found that people tend to regain weight quickly after discontinuing weight-loss medications ...
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...
Emma Dyer says she collapsed on her bathroom floor and began vomiting blood after buying jabs online.
Drugmakers Novo Nordisk and Eli Lilly are battling it out in the GLP-1 weight loss market. The pill version of Novo Nordisk's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results